Ginsenoside Rg1 improves survival in a murine model of polymicrobial sepsis by suppressing the inflammatory response and apoptosis of lymphocytes

Journal of Surgical Research

Volumn 183, Issue 2, 2013, Pages 760-766

  Zou, Yun ^a   Tao, Tianzhu ^a   Tian, Ye ^a   Zhu, Jiali ^a   Cao, Lijun ^a   Deng, Xiaoming ^a   Li, Jinbao ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Anti inflammation; Ginsenoside Rg1; Immune modulation; Sepsis

Indexed keywords

GINSENOSIDE RG 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; BACTERIAL CLEARANCE; CELL MIGRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MECHANISM; HISTOPATHOLOGY; LIVER INJURY; LUNG INJURY; LYMPHOCYTE; MALE; MORTALITY; MOUSE; NEUTROPHIL; NEUTROPHIL COUNT; NONHUMAN; PERITONEAL CAVITY; PERITONEUM LAVAGE; PRIORITY JOURNAL; SEPSIS; SPLEEN; SURVIVAL; THYMUS;

ANTI-INFLAMMATION; GINSENOSIDE RG1; IMMUNE MODULATION; SEPSIS;

ANIMALS; ANTI-INFLAMMATORY AGENTS; APOPTOSIS; CECUM; COINFECTION; DISEASE MODELS, ANIMAL; GINSENOSIDES; INFLAMMATION; LIGATION; LYMPHOCYTES; MALE; MICE; MICE, INBRED C57BL; NEUTROPHILS; PUNCTURES; SEPSIS; SPLEEN; SURVIVAL RATE;

EID: 84880300604     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2013.01.068     Document Type: Article

References (36)

1. M.M. Levy, M.P. Fink, and J.C. Marshall 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference Intensive Care Med 29 2003 530
2. G.S. Martin, D.M. Mannino, S. Eaton, and M. Moss The epidemiology of sepsis in the United States from 1979 through 2000 N Engl J Med 348 2003 1546
3. R.C. Bone The pathogenesis of sepsis Ann Intern Med 115 1991 457
4. C.T. Esmon, K. Fukudome, and T. Mather Inflammation, sepsis, and coagulation Haematologica 84 1999 254
5. L.P. Skrupky, P.W. Kerby, and R.S. Hotchkiss Advances in the management of sepsis and the understanding of key immunologic defects Anesthesiology 115 2011 1349
6. I. Cinel, and R.P. Dellinger Advances in pathogenesis and management of sepsis Curr Opin Infect Dis 20 2007 345
7. P.A. Ward Immunosuppression in sepsis JAMA 306 2011 2618
8. K.W. Leung, and A.S. Wong Pharmacology of ginsenosides: a literature review Chin Med 5 2010 20
9. J.F. Hu, X.Y. Song, and S.F. Chu Inhibitory effect of ginsenoside Rg1 on lipopolysaccharide-induced microglial activation in mice Brain Res 1374 2011 8
10. J. Du, B. Cheng, X. Zhu, and C. Ling Ginsenoside Rg1, a novel glucocorticoid receptor agonist of plant origin, maintains glucocorticoid efficacy with reduced side effects J Immunol 187 2011 942
11. E.J. Lee, E. Ko, and J. Lee Ginsenoside Rg1 enhances CD4(+) T-cell activities and modulates Th1/Th2 differentiation Int Immunopharmacol 4 2004 235
12. J. Wu, Z. Pan, and Z. Wang Ginsenoside Rg1 protection against beta-amyloid peptide-induced neuronal apoptosis via estrogen receptor alpha and glucocorticoid receptor-dependent anti-protein nitration pathway Neuropharmacology 63 2012 349
13. D. Zhu, L. Wu, and C.R. Li Ginsenoside Rg1 protects rat cardiomyocyte from hypoxia/reoxygenation oxidative injury via antioxidant and intracellular calcium homeostasis J Cell Biochem 108 2009 117
14. W.J. Hubbard, M. Choudhry, and M.G. Schwacha Cecal ligation and puncture Shock 24 Suppl 1 2005 52
15. Y. Tanino, H. Makita, and K. Miyamoto Role of macrophage migration inhibitory factor in bleomycin-induced lung injury and fibrosis in mice Am J Physiol Lung Cell Mol Physiol 283 2002 L156
16. D.E. Fry Sepsis, systemic inflammatory response, and multiple organ dysfunction: the mystery continues Am Surg 78 2012 1
17. R.S. Hotchkiss, and I.E. Karl The pathophysiology and treatment of sepsis N Engl J Med 348 2003 138
18. I. Herzum, and H. Renz Inflammatory markers in SIRS, sepsis and septic shock Curr Med Chem 15 2008 581
19. H. Xiao, J. Siddiqui, and D.G. Remick Mechanisms of mortality in early and late sepsis Infect Immun 74 2006 5227
20. A. Namath, and A.J. Patterson Genetic polymorphisms in sepsis Crit Care Clin 25 2009 835
21. C. Pierrakos, and J.L. Vincent Sepsis biomarkers: a review Crit Care 14 2010 R15
22. M.F. Osuchowski, K. Welch, J. Siddiqui, and D.G. Remick Circulating cytokine/inhibitor profiles reshape the understanding of the SIRS/CARS continuum in sepsis and predict mortality J Immunol 177 2006 1967
23. J.W. van den Berg, M. van der Zee, and R.W. de Bruin Mild versus strong anti-inflammatory therapy during early sepsis in mice: a matter of life and death Crit Care Med 39 2011 1275
24. C.J. Fisher Jr., J.M. Agosti, and S.M. Opal Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group N Engl J Med 334 1996 1697
25. E.A. Panacek, J.C. Marshall, and T.E. Albertson Efficacy and safety of the monoclonal anti-tumor necrosis factor antibody F(ab')2 fragment afelimomab in patients with severe sepsis and elevated interleukin-6 levels Crit Care Med 32 2004 2173
26. J.C. Alves-Filho, A. de Freitas, F. Spiller, F.O. Souto, and F.Q. Cunha The role of neutrophils in severe sepsis Shock 30 Suppl 1 2008 3
27. C.F. Benjamim, S.H. Ferreira, and F.Q. Cunha Role of nitric oxide in the failure of neutrophil migration in sepsis J Infect Dis 182 2000 214
28. M. Korivi, C.W. Hou, and C.Y. Huang Ginsenoside-Rg1 protects the liver against Exhaustive exercise-induced oxidative stress in tats Evid Based Complement Alternat Med 2012 2012 932165
29. J.S. Boomer, K. To, and K.C. Chang Immunosuppression in patients who die of sepsis and multiple organ failure JAMA 306 2011 2594
30. R.S. Hotchkiss, P.E. Swanson, and C.M. Knudson Overexpression of Bcl-2 in transgenic mice decreases apoptosis and improves survival in sepsis J Immunol 162 1999 4148
31. N. Matsuda, S. Yamamoto, and K. Takano Silencing of fas-associated death domain protects mice from septic lung inflammation and apoptosis Am J Respir Crit Care Med 179 2009 806
32. C. Oberholzer, A. Oberholzer, M. Clare-Salzler, and L.L. Moldawer Apoptosis in sepsis: a new target for therapeutic exploration FASEB J 15 2001 879
33. S.M. van Schaik, and A.K. Abbas Role of T cells in a murine model of Escherichia coli sepsis Eur J Immunol 37 2007 3101
34. J. Geng, W. Peng, Y. Huang, H. Fan, and S. Li Ginsenoside-Rg1 from Panax notoginseng prevents hepatic fibrosis induced by thioacetamide in rats Eur J Pharmacol 634 2010 162
35. X.S. Xie, H.C. Liu, and F.P. Wang Ginsenoside Rg1 modulation on thrombospondin-1 and vascular endothelial growth factor expression in early renal fibrogenesis in unilateral obstruction Phytother Res 24 2010 1581
36. W.S. Lau, W.F. Chen, R.Y. Chan, D.A. Guo, and M.S. Wong Mitogen-activated protein kinase (MAPK) pathway mediates the oestrogen-like activities of ginsenoside Rg1 in human breast cancer (MCF-7) cells Br J Pharmacol 156 2009 1136